Riding the wave on latest obesity buyout; Slack interview with anti-aging researcher; Two new IRA lawsuits; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
As summer comes to an end, we are getting ready to launch a fresh back-to-school look for the Endpoints Weekly. Thanks as always for your readership, and stay tuned!
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.